Analyze Diet
Veterinary immunology and immunopathology2010; 138(3); 198-205; doi: 10.1016/j.vetimm.2010.07.027

Effects of two commercially available immunostimulants on leukocyte function of foals following ex vivo exposure to Rhodococcus equi.

Abstract: The objective of this study was to determine the effect of immunostimulants on neutrophil, macrophage, and lymphocyte function following ex vivo exposure to Rhodococcus equi. Eighteen foals were randomly assigned to one of 3 treatment groups. Treatment consisted of inactivated Propionibacterium acnes (PA), inactivated parapoxvirus ovis (PPVO), or saline (control) administered on days 0 (7 days of age), 2, and 8. Bronchoalveolar lavage (BAL) fluid and blood were collected on days 0 (baseline), 12, 24 and 36. Intracellular replication of R. equi in macrophages, cytokine induction by R. equi-infected macrophages, phagocytic and oxidative burst activity of neutrophils, lymphoproliferative responses, and cytokine induction of proliferating lymphocytes were measured. Neutrophils from foals treated with PPVO had significantly greater ability to phagocytize R. equi and undergo oxidative burst on day 12 and day 24 compared to baseline values. On day 24, foals treated with PPVO had significantly greater phagocytosis and oxidative burst than foals treated with PA. Treatment with PA resulted in significantly less intracellular proliferation of R. equi within monocyte-derived macrophages on day 12 compared to control foals. The ability of R. equi to replicate in BAL macrophages decreased significantly (P=0.005) with time with lower replication in BAL macrophages of older foals compared to younger foals, regardless of treatment. On day 12, TNF-α induction in monocyte-derived macrophages and IL-12 p40 induction in BAL macrophages infected with R. equi was significantly higher in foals treated with PPVO than in controls. Lymphoproliferative responses and IFN-γ induction were not significantly different between groups.
Publication Date: 2010-08-06 PubMed ID: 20822815DOI: 10.1016/j.vetimm.2010.07.027Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates how two commercially available immunostimulants impact the function of certain white blood cells in foals after exposure to the bacterium, Rhodococcus equi.

Study Objective and Design

  • The primary goal of this research was to understand the influence of immunostimulants on three types of white blood cells – neutrophils, macrophages, and lymphocytes – after these cells were exposed to Rhodococcus equi ex vivo (outside a living organism).
  • The researchers used 18 foals in their study, dividing them randomly into three treatment groups. The treatments involved the use of inactivated Propionibacterium acnes (PA), inactivated parapoxvirus ovis (PPVO), or a saline solution (serving as a control), delivered on specific days of the experiment.
  • The research team collected bronchoalveolar lavage (BAL) fluid and blood from the foals at regular intervals over 36 days to measure various cell functions and changes.

Main Findings

  • The study found noticeable improvements in neutrophils’ ability to phagocytize (engulf and destroy) Rhodococcus equi and trigger oxidative bursts (a mechanism immune cells use to destroy pathogens) in foals treated with PPVO, compared to the baseline data.
  • On the 24th day, the PPVO-treated foals exhibited better neutrophilic phagocytosis and oxidative burst activity than those treated with PA.
  • The researchers observed that PA treatment significantly inhibited the proliferation of Rhodococcus equi within monocyte-derived macrophages (a type of white blood cell) on the 12th day compared to the control group.
  • The capacity of Rhodococcus equi to multiply within BAL macrophages lessened notably over time, with older foals showing lower replication rates than younger ones, disregarding the treatment type.
  • Also, on the 12th day, the foals treated with PPVO showed significantly higher induction of two types of immune-system-activating proteins (TNF-α and IL-12 p40) in monocyte-derived macrophages and BAL macrophages infected with Rhodococcus equi compared to the control group.
  • The study found no marked difference among the groups in terms of lymphoproliferative responses (the ability of lymphocytes to multiply) and IFN-γ induction (an important protein for immune responses).

Overall Interpretation

  • The results imply that while the use of commercially available immunostimulants can have differential effects on the immune responses of foals, one stimulant (PPVO) seemed to enhance certain key aspects more effectively than the other (PA).
  • Future studies will help unfold any potential clinical applications or implication of these findings, particularly in the context of therapies for Rhodococcus equi infections in horses.

Cite This Article

APA
Ryan C, Giguère S, Fultz L, Long MT, Crawford PC. (2010). Effects of two commercially available immunostimulants on leukocyte function of foals following ex vivo exposure to Rhodococcus equi. Vet Immunol Immunopathol, 138(3), 198-205. https://doi.org/10.1016/j.vetimm.2010.07.027

Publication

ISSN: 1873-2534
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 138
Issue: 3
Pages: 198-205

Researcher Affiliations

Ryan, Clare
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA.
Giguère, Steeve
    Fultz, Lisa
      Long, Maureen T
        Crawford, P Cynda

          MeSH Terms

          • Actinomycetales Infections / immunology
          • Actinomycetales Infections / veterinary
          • Adjuvants, Immunologic / pharmacology
          • Animals
          • Animals, Newborn
          • Cytokines / biosynthesis
          • Cytokines / genetics
          • Horse Diseases / immunology
          • Horses / immunology
          • In Vitro Techniques
          • Leukocytes / drug effects
          • Leukocytes / immunology
          • Leukocytes / microbiology
          • Lymphocyte Activation / drug effects
          • Macrophages, Alveolar / drug effects
          • Macrophages, Alveolar / immunology
          • Macrophages, Alveolar / microbiology
          • Neutrophils / drug effects
          • Neutrophils / immunology
          • Neutrophils / microbiology
          • Parapoxvirus / immunology
          • Propionibacterium acnes / immunology
          • RNA, Messenger / genetics
          • RNA, Messenger / metabolism
          • Respiratory Burst / drug effects
          • Rhodococcus equi / immunology
          • Rhodococcus equi / pathogenicity
          • Vaccines, Inactivated / pharmacology

          Citations

          This article has been cited 4 times.
          1. Picetti TS, Soveral LF, Miotto R, Erpen LMS, Kreutz Y, Guizzo JA, Frandoloso R, Kreutz LC. Orally administered β-glucan improves the hemolytic activity of the complement system in horses. Vet World 2021 Apr;14(4):835-840.
          2. Hue ES, Richard EA, Fortier CI, Fortier GD, Paillot R, Raue R, Pronost SL. Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment. Vaccines (Basel) 2017 Sep 19;5(3).
            doi: 10.3390/vaccines5030028pubmed: 28925977google scholar: lookup
          3. Anziliero D, Weiblen R, Kreutz LC, Spilki F, Flores EF. Inactivated Parapoxvirus ovis induces a transient increase in the expression of proinflammatory, Th1-related, and autoregulatory cytokines in mice. Braz J Med Biol Res 2014 Feb;47(2):110-8.
            doi: 10.1590/1414-431X20133358pubmed: 24519126google scholar: lookup
          4. da Silveira BP, Cohen ND, Lawhon SD, Watson RO, Bordin AI. Protective immune response against Rhodococcus equi: An innate immunity-focused review. Equine Vet J 2025 May;57(3):563-586.
            doi: 10.1111/evj.14214pubmed: 39258739google scholar: lookup